Dr. John Olkowski, a well-known corneal specialist, developed the NuLids System to address his growing frustration with the fact that his Dry Eye patients' symptoms were not improving despite his in-office and conventional at-home treatments.

Dry eye affects 40 million people in the United States, and the number is growing both clinically and anecdotally. NuLids made its way into the consumer market as a safe, effective, low-cost, and time-efficient solution, backed by a prestigious list of doctors and universities. As a stand-alone, first-line treatment, NuLids has demonstrated remarkable improvements over other dry eye treatments, as well as a solution for additional concerns such as excessive screen time, environmental aggressors, and preventative treatment.